Assembly Biosciences

This early-stage study tested the safety and how the body processes a new experimental drug called ABI-5366. It involved 115 healthy volunteers and people with recurrent genital herpes. The main goals were to check for side effects, measure drug levels in the blood, and see if th…

This early-stage study tested the safety and how the body processes a new drug called ABI-1179. It involved 103 healthy volunteers and people with recurrent genital herpes caused by HSV-2. The main goal was to see if the drug was safe and to measure its levels in the blood over t…

This early-stage study tested the safety of ABI-6250, a potential treatment for Hepatitis D, in 40 healthy volunteers. Researchers gave participants single and multiple doses to check for side effects and measure how the drug moves through the body. The study also examined whethe…